Evidence map›Paper›PMID 31236724›Full record

ArticleSurgical endoscopy2020

Predicting surgical site infections following laparoscopic bariatric surgery: development of the BariWound tool using the MBSAQIP database.

Jerry T Dang, Caroline Tran, Noah Switzer, Megan Delisle, Michael Laffin, Karen Madsen, Daniel W Birch, Shahzeer Karmali

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06510452 (Efficacy of Antibiotic Prophylaxis in Metabolic Bariatric Surgery), which is not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06510452 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Antibiotic Prophylaxis in Metabolic Bariatric Surgery: A Randomized Controlled Trial

TypeinterventionalSponsorGeneral Committee of Teaching Hospitals and Institutes, EgyptRan2024 to 2026Enrolled3,352ConditionsAntibiotic Reaction, Wound Infection Superficial, Wound Infection Deep, Bariatric Surgery CandidateArms2000 mg of Cefazolin, 500 mg of Metronidazole IV, NACL 0.9% 100 ml
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jerry T DangDepartment of Surgery, University of Alberta, Edmonton, AB, Canada. dang2@ualberta.ca.ORCID http://orcid.org/0000-0001-8659-0934
Caroline TranCentre for the Advancement of Surgical Education and Simulation, Edmonton, AB, Canada.
Noah SwitzerOhio State University, Columbus, OH, USA.
Megan DelisleDepartment of Surgery, University of Manitoba, Winnipeg, MB, Canada.
Michael LaffinDepartment of Surgery, University of Alberta, Edmonton, AB, Canada.
Karen MadsenDepartment of Medicine, University of Alberta, Edmonton, AB, Canada.
Daniel W BirchDepartment of Surgery, University of Alberta, Edmonton, AB, Canada.
Shahzeer KarmaliDepartment of Surgery, University of Alberta, Edmonton, AB, Canada.
University of Alberta · CAThe Ohio State University · USUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough bariatric surgery is a safe procedure for severe obesity, incisional surgical site infections (SSI) remain a significant cause of morbidity. Bariatric surgery patients are at high risk due to obesity and diabetes. The objective of this study was to develop a predictive tool for incisional SSI within 30 days of bariatric surgery.

methodsData were retrieved from the 2015 and 2016 MBSAQIP databases. This study included patients who underwent primary laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG). The primary outcome of interest was incisional SSI occurring within 30 days. Surgeries performed in 2015 were used in a derivation cohort and the predictive tool was validated against the 2016 cohort. A forward selection algorithm was used to build a logistic regression model predicting probability of SSI.

resultsA total of 274,187 patients were included with 71.7% being LSG and 28.3% LRYGB. 0.7% of patients had a SSI in which 71.0% had an incisional SSI, and 29.9% had an organ/space SSI. Of patients who had an incisional SSI, 88.7% were superficial, 10.9% were deep, and 0.4% were both. A prediction model to assess for risk of incisional SSI, BariWound, was derived and validated. BariWound consists of procedure type, chronic steroid or immunosuppressant use, gastroesophageal reflux disease, obstructive sleep apnea, sex, type 2 diabetes, hypertension, operative time, and body mass index. It stratifies individuals into very high (> 10%), high (5-10%), medium (1-5%), and low risk (< 1%) groups. This model accurately predicted events in the validation cohort with an area under the receiver operating characteristic curve of 0.73.

conclusionsBariWound accurately predicted the risk of 30-day incisional SSI in individuals undergoing bariatric surgery. Stratifying low- and high-risk groups allows for customized SSI prophylactic measures for patients in various risk categories and potentially enables future research targeted at high-risk patients.

Indexed as

AdolescentAdultBariatric SurgeryDatabases, FactualFemaleGastrectomyHumansLaparoscopyMaleMiddle AgedSurgical Wound InfectionTool Use BehaviorTreatment OutcomeYoung AdultBariatric surgeryRoux-en-Y gastric bypassSleeve gastrectomySurgical site infectionsWound infections

Identifiers

PMID31236724
OpenAlexW2953121580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.